NPM1 and acute myeloid leukemia: Forghieri et al. recommended an integrated molecular and immunohistochemical approach by demonstrating NPM1 mutation in the bone marrow and extensive NPMc+ staining in more than 20% blasts in a bone marrow core biopsy to increase a successful diagnosis of AML with mutated NPM1 [118].